Human Amniotic Membrane
Human Amniotic Membrane (HAM) is a common product used for treating several ocular surface disorders within ophthalmology and other wound healing applications. Despite being the current gold standard, the failure rate of HAM during surgery is between 33-44% which can increase the patient’s risk of complications post-surgery.
HAM is acquired from elective caesarean patients and in hospitals with the facilities to harvest and post-process the donated tissues. This means that HAM is in limited supply. Furthermore, the use of these human tissues requires stringent serology tests of donors, a special tissue banking facility for storage and extensive traceability measures. All of which drives up health care costs and challenges the accessibility of treatment to patients.